Napačna izbira? Nič za to! Izdelke lahko vrnete do 30 dni
Z darilnim bonom ne morete zgrešiti. Obdarovanec lahko v zameno za darilni bon izbere karkoli iz naše ponudbe.
Do 30 dni za vračilo
Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer after nonspecific invasive carcinoma (NSCLC). Its frequency is estimated to be between 1 and 15% of invasive breast tumors. It is a particular clinico-pathological entity, characterized by a difficult clinical and radiological diagnosis. The diagnosis is anatomopathological. It is often associated with lobular carcinoma in situ (LCIS). The latter is part of non-invasive lobular neoplasia (NLNI) which is a lesional spectrum of atypical epithelial proliferation originating at the ductulo-lobular end unit. The latest 2019 WHO classification of breast tumors recognizes a new subtype of CLIS which is CLIS florid.
Pozdravljeni! Sem Libroamiko, vaš knjižni svetovalec.
Kako vam lahko pomagam?